PE anti-human CD44 Antibody
- 产品名称：
- PE anti-human CD44 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 338807
- 产品应用：
- 338807
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1548 |
1 |
- Verified Reactivity
- Human
- Reported Reactivity
- African Green, Baboon, Cynomolgus, Rhesus
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- Normal human PBL
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application References
(PubMed link indicates BioLegend citation) -
- Kishimoto T, et al. eds. 1997 Leucocyte Typing VI:White Cell Differentiation Antigen. Garland Publishing Inc.
- Product Citations
-
- Qiao X, et al. 2021. Elife. 10: . PubMed
- Park J, et al. 2021. Exp Ther Med. 22:808. PubMed
- Diessner J, et al. 2014. Cell Death Dis. 5:1149. PubMed
- Liu MY, et al. 2019. Oncol Lett. 18:3664. PubMed
- Palamides P, et al. 2016. Dis Model Mech. 9: 985 - 997. PubMed
- Zeng F, et al. 2021. Cancer Gene Therapy. . PubMed
- Murata K, et al. 2019. Oncol Lett. 17:5830. PubMed
- Floyd T, et al. 2011. J Immunol. 186:2033. PubMed
- Meng YM, et al. 2021. Nat Commun. 12:6011. PubMed
- Cromwell EF, et al. 2022. SLAS Discov. . PubMed
- Kolodziej M, et al. 2019. Adipocyte. 0.509722222. PubMed
- Ross NT, et al. 2020. Nature Chemical Biology. 16(1):50-59.. PubMed
- Kolchakova D, et al. 2021. Biomolecules. 11:. PubMed
- Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
- Labedz-Maslowska A, et al. 2020. Int J Mol Sci. 21:. PubMed
- Liu Y, et al. 2018. Chin J Cancer. 37:2. PubMed
- Wei X, et al. 2019. Int J Mol Med. 44:1425. PubMed
- Wang G, et al. 2018. Int J Mol Med. 41:791. PubMed
- RRID
- AB_2260222 (BioLegend Cat. No. 338807) AB_2076578 (BioLegend Cat. No. 338808)
- Structure
- Variable splicing of CD44 gene generates many CD44 isoforms, 85 kD
- Distribution
-
All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells
- Function
- Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
- Ligand/Receptor
- Hyaluronan, MIP-1β, fibronectin, collagen
- Cell Type
- Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
- Biology Area
- Cell Adhesion, Cell Biology, Immunology, Stem Cells
- Molecular Family
- Adhesion Molecules, CD Molecules
- Antigen References
-
1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
- Gene ID
- 960 View all products for this Gene ID
- UniProt
- View information about CD44 on UniProt.org
